Related Experiment Video
Updated: Aug 28, 2025
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
Emerging Roles of TRIM Family Proteins in Gliomas Pathogenesis
Angeliki-Ioanna Giannopoulou1, Charalampos Xanthopoulos2, Christina Piperi1
1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Abstract:
Gliomas encompass a vast category of CNS tumors affecting both adults and children. Treatment and diagnosis are often impeded due to intratumor heterogeneity and the aggressive nature of the more malignant forms. It is therefore essential to elucidate the molecular mechanisms and explore the intracellular signaling pathways underlying tumor pathology to provide more promising diagnostic, prognostic, and therapeutic tools for gliomas. The tripartite motif-containing (TRIM) superfamily of proteins plays a key role in many physiological cellular processes, including brain development and function. Emerging evidence supports the association of TRIMs with a wide variety of cancers, exhibiting both an oncogenic as well as a tumor suppressive role depending on cancer type. In this review, we provide evidence of the pivotal role of TRIM proteins in gliomagenesis and exploit their potential as prognostic biomarkers and therapeutic targets.
Insights
Tripartite motif-containing (TRIM) proteins are crucial in brain development and gliomagenesis. This review highlights their potential as diagnostic, prognostic, and therapeutic targets for glioma treatment.
Area of Science:
- Neuro-oncology
- Molecular biology
- Cancer research
Background:
- Gliomas are aggressive central nervous system (CNS) tumors with challenging diagnosis and treatment due to heterogeneity.
- Understanding molecular mechanisms and intracellular signaling pathways is vital for developing better glioma diagnostics and therapeutics.
- The tripartite motif-containing (TRIM) protein superfamily is involved in cellular processes, including brain development.
Purpose of the Study:
- To review the role of TRIM proteins in gliomagenesis.
- To explore the potential of TRIM proteins as prognostic biomarkers for gliomas.
- To investigate TRIM proteins as therapeutic targets in glioma treatment.
Main Methods:
- Literature review of studies on TRIM proteins and gliomas.
- Analysis of TRIM protein involvement in cancer, including gliomagenesis.
- Evaluation of TRIM proteins as diagnostic and therapeutic targets.
Main Results:
- TRIM proteins play a significant role in the development of gliomas.
- TRIM proteins exhibit diverse functions in cancer, acting as oncogenes or tumor suppressors.
- Evidence suggests TRIM proteins are implicated in gliomagenesis.
Conclusions:
- TRIM proteins are pivotal in gliomagenesis and represent promising prognostic biomarkers.
- Targeting TRIM proteins offers potential therapeutic strategies for glioma treatment.
- Further research into TRIM proteins could lead to improved diagnostic and therapeutic tools for gliomas.
More Related Videos
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:00Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...